Longitudinal Follow up of Patients With Pleural Effusion
NCT04670562 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-06-22
Summary
This study aims to evaluate the clinical course of patients diagnosed with pleural effusion and determine various clinical factors and biomarkers associated that can predict the diagnosis and clinical outcome and prognosis of patients with pleural effusion due to specific causes.
Conditions
- Pleural Effusion, Malignant
- Prognosis
Sponsors & Collaborators
-
Seoul National University Bundang Hospital
lead OTHER
Principal Investigators
-
Yeon Wook Kim, Professor · Seoul National University Bundang Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2024-12-01
- Completion
- 2025-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion
NCT05693727 ·Status: NOT_YET_RECRUITING
-
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
NCT05587114 ·Status: RECRUITING
-
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
NCT07012759 ·Status: RECRUITING
-
Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer
NCT01179685 ·Status: COMPLETED ·Phase: NA
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN
-
Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion
NCT01256801 ·Status: COMPLETED
-
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
NCT02855281 ·Status: COMPLETED
-
Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion
NCT04263688 ·Status: UNKNOWN
-
The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring
NCT02437760 ·Status: UNKNOWN
-
Bronchoalveolar Lavage Combined With High-throughput Sequencing Technology
NCT07005466 ·Status: COMPLETED
-
Analysis of Metabonomics for Pleural Effusion
NCT05906823 ·Status: COMPLETED
-
Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis
NCT05455034 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
NCT02407912 ·Status: UNKNOWN ·Phase: NA
-
Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
NCT03661801 ·Status: COMPLETED
-
Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion
NCT00313066 ·Status: UNKNOWN
-
Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
NCT04887545 ·Status: UNKNOWN
-
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204 ·Status: ACTIVE_NOT_RECRUITING
-
Symptom Collection of Lung Cancer Patients
NCT03384680 ·Status: UNKNOWN
-
Molecular Profiling of Exosomes in Tumor-draining Vein of Early-staged Lung Cancer
NCT04939324 ·Status: UNKNOWN ·Phase: NA
-
Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study
NCT07331701 ·Status: NOT_YET_RECRUITING
-
Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions
NCT05804786 ·Status: RECRUITING
-
Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites
NCT01369992 ·Status: UNKNOWN
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.
NCT04806412 ·Status: UNKNOWN ·Phase: NA
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN